Enhanced external counterpulsation (EECP) combined with intravenous thrombolysis (IVT) for acute ischemic stroke: a pilot randomized trial

医学 随机对照试验 溶栓 麻醉 心脏病学 内科学 梅德林 心肌梗塞 血压 缺血 外科 临床试验 血流动力学 纤溶剂
作者
Long Wang,Chi Zhang,Dun-Ling Li,Jie Hu,Yu Wang,Qiu-wan Liu,Jia Li,Yuan-yuan Huang,Fuyu Wang,Jun-Cang Wu
出处
期刊:European Journal of Medical Research [BioMed Central]
卷期号:31 (1): 1444-
标识
DOI:10.1186/s40001-026-05071-8
摘要

To assess the safety and efficacy of enhanced external counterpulsation (EECP) when applied early after intravenous thrombolysis (IVT) in acute ischemic stroke (AIS). AIS patients who received IVT were randomly assigned in a 1:1 ratio to the EECP group or the sham-EECP group. EECP (or sham-EECP) was initially performed within 24 h following IVT and continued with daily 30 min sessions for a subsequent period of 10 days. All participants were followed up for a 90-day period. Feasibility was assessed based on the percentage of patients who completed all scheduled EECP treatments following IVT, as well as the percentage of patients for whom EECP was discontinued at the request of doctors or nurses due to potential interference with other treatments. The safety outcomes included the incidence of early neurological deterioration (END), any hemorrhagic transformation (HT), changes in vital signs, and adverse events that occurred during the follow-up period. The effectiveness evaluation was conducted using the modified Rankin Scale (mRS) at 90 days post-treatment. Seventy-three patients (37 in the EECP group and 36 in the sham-EECP group) completed the entire study. No statistically significant differences were observed between the two groups with respect to demographic characteristics or baseline clinical parameters at admission. The median mRS score in the EECP group was significantly lower than that of Sham-EECP group (0 [IQR: 0–1] vs. 1 [IQR: 0–2]; p=0.03), indicating early EECP intervention may enhance functional outcomes in AIS patients receiving IVT. Among all randomized patients, no significant differences were observed in the incidence of serious adverse events, including END and sICH. Treatment-related adverse events such as headache or dizziness during therapy and/or lumbago were reported in four patients (10.8%) and 2 patients (5.6%), respectively, in the EECP group and sham-EECP group. This pilot study indicates that EECP may be both safe and potentially beneficial for AIS patients receiving IVT. Further larger-scale, prospective studies are needed to verify the efficacy of EECP in this population. Clinical trial registration and registry URL ChiCTR2400080746, registered at www. chictr. org. cn, 2024/2/6.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yeeee发布了新的文献求助10
刚刚
三秋发布了新的文献求助10
1秒前
匆匆发布了新的文献求助10
1秒前
Waitcy发布了新的文献求助10
1秒前
晚庾发布了新的文献求助10
2秒前
Azura完成签到 ,获得积分10
2秒前
大个的应助被风吹麦浪采纳,获得10
2秒前
东风的应助被风吹麦浪采纳,获得30
2秒前
小马甲的应助被风吹麦浪采纳,获得10
3秒前
科目三的应助被风吹麦浪采纳,获得10
3秒前
3秒前
脑洞疼的应助被Cuillli采纳,获得10
4秒前
小蘑菇的应助被凪凪采纳,获得10
4秒前
搜集达人的应助被负责金毛采纳,获得10
4秒前
cheng完成签到,获得积分10
5秒前
彭于晏的应助被eating采纳,获得10
5秒前
5秒前
康谨发布了新的文献求助10
5秒前
6秒前
三秋完成签到,获得积分10
6秒前
科目三的应助被动人的向松采纳,获得30
6秒前
myx发布了新的文献求助10
6秒前
7秒前
7秒前
xzcx发布了新的文献求助10
7秒前
谦让的发箍完成签到,获得积分10
7秒前
闫大蛇发布了新的文献求助10
9秒前
9秒前
上官若男的应助被曾经凌萱采纳,获得10
9秒前
9秒前
10秒前
空集发布了新的文献求助10
10秒前
themoomofeye完成签到 ,获得积分10
10秒前
lalala发布了新的文献求助10
11秒前
凪凪完成签到,获得积分10
11秒前
12秒前
12秒前
想吃泡粉发布了新的文献求助20
12秒前
852的应助被gg采纳,获得10
13秒前
wwq发布了新的文献求助10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193925
求助须知:如何正确求助?哪些是违规求助? 9579945
关于积分的说明 21868504
捐赠科研通 7793568
什么是DOI,文献DOI怎么找? 3437462
关于科研通互助平台的介绍 2560923
邀请新用户注册赠送积分活动 2484250